Fluoroquinolone resistance in Neisseria meningitidis in Spain

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 2, 2008, Pages 286-290

  Enríquez, Rocío ^a   Abad, Raquel ^a   Salcedo, Celia ^a   Pérez, Sonia ^a   Vázquez, Julio A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Ciprofloxacin; Meningococci; QRDRs

Indexed keywords

ASPARAGINE; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; HISTIDINE; ISOLEUCINE; PENICILLIN G; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; THREONINE;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHILD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; INFANT; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; SPAIN;

ADOLESCENT; ADULT; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; SPAIN;

EID: 38349094212     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm452     Document Type: Article

References (13)

1. Dworzack DL, Sanders CC, Horowitz EA et al. Evaluation of single-dose ciprofloxacin in the erradication of Neisseria meningitidis from nasopharyngeal carders. Antimicrob Agents Chemother 1988; 39: 1740-1.
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing., Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
3. Block C, Vazquez JA. Antibiotic resistance. In: Frosch M, Maiden MCJ, eds. Handbook of Meningococcal Disease. Infection Biology, Vaccination, Clinical Management. Weinheim, Germany: Wiley-VCH, 2006; 53-76.
4. Corso A, Faccone D, Miranda M et al. Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina. J Antimicrob Chemother 2005; 55: 596-7.
5. Dewi BE, Akira S, Hayashi H et al. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae. Sex Transm Dis 2004; 31: 353-9.
6. Shultz TR, White PA, Tapsall JW. In vitto assessment of the further potential for development of fluoroquinolone resistance in Neisserria meningitidis. Antimicrob Agents Chemother 2005; 49: 1753-60.
7. Arreaza L, De la Fuente L, Vázquez JA. Antibiotic susceptibility patterns of Neisseria meningitidis isolates from patients and asymptomatic carriers. Antimicrob Agents Chemother 2000; 44: 1705-7.
8. Deguchi T, Yasuda M, Nakano M et al. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 1996; 40: 2437-8.
9. Stefanelli P, Fazio C, La Rosa G et al. Rifampicin-resistant meningococci causing invasive disease: Detection of point mutations in the rpoB gene and molecular characterization of the strains. J Antimicrob Chemother 2001; 47: 219-22.
10. Lindback E, Islam S, Unemo M et al. Mutations in gyrA, gyrB, parC and parE in quinolone-resitant strains of Neisseria gonorhoeae. APMIS 2002; 110: 651-7.
11. Lindback E, Islam S, Unemo M et al. Transformation of ciprofloxacin-resistant Neisseria gonorrhoeae gyrA, parE and porB1b genes. Int J Antimicrob Agents 2006; 28: 206-11.
12. Hagman KE, Pan W, Spratt BG et al. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology 1995; 141: 611-22.
13. Rouquette-Loughlin CE, Balthazar JT, Hill SA et al. Modulation of the mtrCDE-encoded efflux pump gone complex of Neisseria meningitidis due to a Correia element insertion sequence. Mol Microbiol 2004; 54: 731-41.